SciELO - Scientific Electronic Library Online

 
vol.24 número2Seroprevalencia y seroconversión de anticuerpos contra el virus JC en una cohorte de pacientes mexicanos con esclerosis múltiple índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Revista mexicana de neurociencia

versión On-line ISSN 2604-6180versión impresa ISSN 1665-5044

Resumen

CERVANTES-ARRIAGA, Amin et al. Neuropsychiatric and young-onset as clinical determinants for a delayed Huntington's disease diagnosis. Rev. mex. neurocienc. [online]. 2023, vol.24, n.2, pp.30-36.  Epub 12-Jun-2023. ISSN 2604-6180.  https://doi.org/10.24875/rmn.22000055.

Objective:

This study aims to identify the possible factors that delay the time-to-diagnosis of Huntington's disease (HD).

Methods:

A cross-sectional study in HD patients was carried out. Variables registered were CAG repeats, age of onset, primary symptom at onset, age of molecular diagnosis, and time-to-diagnosis, among others.

Results:

107 patients (50.5% female) with a mean age of 49 ± 12.8 years (y) were included in the study. Median CAG size was 45 (38-73). Mean age of onset, mean age of molecular diagnosis, and mean time-to-diagnosis were 39 ± 12.9, 45.1 ± 12.1, and 6.4 ± 6.4 years, respectively. In the comparative analysis, the neuropsychiatric- and the young-onset groups had a longer time-to-diagnosis than the motor- and typical-onset groups (p = 0.02 and p < 0.01, respectively). In the linear regression analysis, neuropsychiatric- and young-onset were independent risk factors.

Conclusions:

Delayed diagnosis showed relation to neuropsychiatric- and early-onset in HD.

Palabras llave : Huntington's disease; Molecular pathology; Delayed diagnosis; Age of onset.

        · resumen en Español     · texto en Inglés     · Inglés ( pdf )